Cathrine Cody serves as the Medical Account Associate Director for Managed Markets at Novo Nordisk, where she leverages her extensive background as a board-certified pharmacotherapy specialist to drive clinical and scientific engagement across priority managed market accounts. In her role, Cathrine is instrumental in developing...
Cathrine Cody serves as the Medical Account Associate Director for Managed Markets at Novo Nordisk, where she leverages her extensive background as a board-certified pharmacotherapy specialist to drive clinical and scientific engagement across priority managed market accounts. In her role, Cathrine is instrumental in developing and executing strategies that align clinical insights with business objectives, ensuring that Novo Nordisk's innovative therapies are effectively integrated into pharmacy benefit management systems. Her expertise in managed care, drug information, and utilization management allows her to navigate complex healthcare systems and advocate for safe, appropriate, and cost-effective drug use.
Cathrine is currently leading key projects that focus on enhancing medication therapy management and optimizing formulary placement for Novo Nordisk products. By collaborating with healthcare providers and payers, she translates clinical data into actionable strategies that support patient access to essential medications. Her passion for promoting evidence-based practices is evident in her commitment to educating stakeholders about the clinical benefits of Novo Nordisk’s offerings, ultimately aiming to improve patient outcomes and streamline healthcare delivery.
With a strong foundation in pharmacy practice and a keen understanding of health care systems, Cathrine is adept at identifying opportunities for innovation within managed markets. She is dedicated to fostering partnerships that enhance the value of pharmaceutical care while addressing the evolving needs of patients and providers alike. Through her strategic initiatives, Cathrine continues to make a significant impact in the field, ensuring that Novo Nordisk remains at the forefront of advancing health outcomes in managed care environments.
